ST
AZN icon

Smithfield Trust’s AstraZeneca AZN Stock Holding History

Smithfield Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$409K Buy
2,117
+4
+0.2% +$771 0.02% 273
2025
Q4 		$388K Buy
2,113
+124
+6% +$21.7K 0.02% 266
2025
Q3 		$304K Hold
1,989
– – 0.01% 289
2025
Q2 		$279K Hold
1,989
– – 0.01% 295
2025
Q1 		$292K Sell
1,989
-85
-4% -$12.3K 0.01% 274
2024
Q4 		$271K Sell
2,074
-236
-10% -$33K 0.01% 295
2024
Q3 		$358K Buy
2,310
+236
+11% +$38.1K 0.02% 254
2024
Q2 		$322K Sell
2,074
-21
-1% -$3.16K 0.02% 252
2024
Q1 		$285K Sell
2,095
-10
-0.5% -$1.32K 0.02% 273
2023
Q4 		$284K Hold
2,105
– – 0.02% 267
2023
Q3 		$285K Hold
2,105
– – 0.02% 249
2023
Q2 		$300K Hold
2,105
– – 0.02% 251
2023
Q1 		$291K Hold
2,105
– – 0.02% 249
2022
Q4 		$286K Sell
2,105
-435
-17% -$54.6K 0.02% 244
2022
Q3 		$278K Sell
2,540
-615
-19% -$78K 0.02% 234
2022
Q2 		$419K Buy
3,155
+1,018
+48% +$134K 0.03% 189
2022
Q1 		$285K Sell
2,137
-74
-3% -$8.87K 0.02% 253
2021
Q4 		$256K Sell
2,211
-7
-0.3% -$824 0.02% 283
2021
Q3 		$264K Buy
2,218
+193
+10% +$22.5K 0.02% 266
2021
Q2 		$242K Hold
2,025
– – 0.02% 285
2021
Q1 		$201K Buy
2,025
+304
+18% +$30.6K 0.01% 308
2020
Q4 		$173K Sell
1,721
-1,032
-37% -$109K 0.01% 335
2020
Q3 		$302K Sell
2,753
-40
-1% -$4.45K 0.02% 224
2020
Q2 		$296K Hold
2,793
– – 0.03% 219
2020
Q1 		$249K Sell
2,793
-52
-2% -$4.89K 0.03% 208
2019
Q4 		$284K Sell
2,845
-193
-6% -$18.2K 0.03% 221
2019
Q3 		$271K Buy
3,038
+827
+37% +$71.7K 0.03% 224
2019
Q2 		$182K Buy
2,211
+112
+5% +$8.78K 0.02% 281
2019
Q1 		$170K Hold
2,099
– – 0.02% 278
2018
Q4 		$160K Buy
2,099
+1,480
+239% +$116K 0.02% 268
2018
Q3 		$49K Hold
619
– – 0.01% 535
2018
Q2 		$43K Hold
619
– – 0.01% 548
2018
Q1 		$43K Sell
619
-45
-7% -$3.12K 0.01% 528
2017
Q4 		$46K Hold
664
– – 0.01% 539
2017
Q3 		$45K Hold
664
– – 0.01% 532
2017
Q2 		$45K Hold
664
– – 0.01% 535
2017
Q1 		$41K Sell
664
-28
-4% -$1.63K 0.01% 550
2016
Q4 		$38K Hold
692
– – 0.01% 551
2016
Q3 		$45K Buy
692
+23
+3% +$1.5K 0.01% 527
2016
Q2 		$40K Hold
669
– – 0.01% 525
2016
Q1 		$38K Hold
669
– – 0.01% 523
2015
Q4 		$45K Hold
669
– – 0.01% 500
2015
Q3 		$43K Sell
669
-15
-2% -$987 0.01% 502
2015
Q2 		$44K Hold
684
– – 0.01% 528
2015
Q1 		$47K Sell
684
-47
-6% -$3.27K 0.01% 526
2014
Q4 		$51K Hold
731
– – 0.01% 507
2014
Q3 		$52K Hold
731
– – 0.01% 514
2014
Q2 		$54K Hold
731
– – 0.01% 530
2014
Q1 		$47K Hold
731
– – 0.01% 538
2013
Q4 		$43K Hold
731
– – 0.01% 532
2013
Q3 		$38K Sell
731
-1
-0.1% -$50 0.01% 526
2013
Q2 		$35K Buy
+732
New +$37.3K 0.01% 517

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Smithfield Trust's AZN Position: Q1 2026 in Review

Smithfield Trust increased its AstraZeneca (AZN) stake by 0.19% in Q1 2026, buying an estimated $771 and bringing the position to 2,117 shares worth $409K. The position accounts for 0.02% of the portfolio, ranked #273.

Smithfield Trust first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $419K in Q2 2022. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Smithfield Trust held 2,117 shares of AstraZeneca worth $409K as of Q1 2026.
  • Smithfield Trust bought 4 AstraZeneca shares in Q1 2026, an estimated $771.
  • AstraZeneca made up 0.02% of Smithfield Trust's portfolio in Q1 2026, its #273 holding.
  • Smithfield Trust first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
  • Smithfield Trust's AstraZeneca position peaked at $419K in Q2 2022.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.